采用普通肝素抗凝。
结果：低分子肝素疗效优于普通肝素，且并发症少。
Result: LMWH was better than common heparin in treating ACS patients, the complications of LMWH is less.
他们比普通肝素更有效、更安全、更方便，费用也低。
They are more efficacious and safer than unfractionated heparin, more convenient and cost effective.
心房颤动消融术中为达到治疗国际标准化比值普通肝素的用量应为多少？
How Much Amount of Heparin should be used in the Atrial Fibrillation Ablation with therapeutic International Normalized Ratio?
在普通肝素中按一定比例加入低分子量肝素将更有利于制品血栓安全性的提高。
The existence of certain amount of low-molecular-weight heparin in ordinary heparin would increase the thrombogenic safety of the concentrate more greatly.
不管是否服用氯吡格雷，依诺肝素都较普通肝素具有更明显的安全性和有效性。
The significantly improved safety and efficacy profile of enoxaparin versus unfractionated heparin was maintained regardless of clopidogrel administration.
结论：进展性脑卒中发病后6 ~48小时，进展较快推荐静脉滴注普通肝素。
Conclusion: Intravenous drip of heparin sodium is recommended for those status progress rapidly after progressive stroke attack from 6 to 48 hours.
观察低分子量肝素在血液透析中的抗凝效果，比较与普通肝素在护理方面的不同处理。
To observe the anticoagulation effect of low molecular weight heparin on hemodialysis and to study its related nursing aspect.
脱硫酸肝素组与普通肝素组在PT、APTT方面均存在显著性差异（P<0.05）。
The regular heparin group showed significant difference in the level of PT and APTT compared with the N-desulfated heparin group(P<0.05).
因此，血液灌流抢救急性药物中毒的抗凝方法中低分子肝素钙明显优于无肝素法和普通肝素法。
We conclude that low molecular heparinate is superior to the other methods for anticoagulation in emergence treatment of acute p…
这些研究比较了血液稀释剂普通肝素和安慰剂、低分子肝素和安慰剂或是两种肝素之间的作用比较。
The studies compared the blood-thinner unfractionated heparin to a placebo, or low-molecular-weight heparin with a placebo, or both types of heparin with each other.
结论：与标准剂量的普通肝素相比，低剂量普通肝素不能减少主要的PCI相关的出血和血管穿刺点并发症的发生。
Conclusion Low-dose compared with standard-dose unfractionated heparin did not reduce major peri-PCI bleeding and vascular access-site complications.
目的探讨在择期经皮冠状动脉介入（PCI）治疗中静脉应用伊诺肝素的有效性和安全性以及与普通肝素对比的疗效差别。
Objective To investigate the effectiveness and safety of intravenous enoxaparin application in PCI and its therapeutic effect compared with unfractionated heparin.
目的：比较在用磺达肝素治疗过的非ST段抬高性急性冠脉综合症的高危患者行PCI时使用的两种不同剂量普通肝素的安全性。
Objective To compare the safety of 2 unfractionated heparin regimens during PCI in high-risk patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux.
目的：比较在用磺达肝素治疗过的非ST段抬高性急性冠脉综合症的高危患者行PCI时使用的两种不同剂量普通肝素的安全性。
Objective To compare the safety of 2 unfractionated heparin regimens during PCI in high-risk patients with non–ST-segment elevation acute coronary syndromes initially treated with fondaparinux.
应用推荐